| Title |
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs
|
|---|---|
| Published in |
Clinical and Translational Medicine, March 2017
|
| DOI | 10.1186/s40169-017-0140-y |
| Pubmed ID | |
| Authors |
George E. Naoum, Zeng B. Zhu, Donald J. Buchsbaum, David T. Curiel, Waleed O. Arafat |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 22 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 3 | 14% |
| Student > Ph. D. Student | 3 | 14% |
| Student > Bachelor | 2 | 9% |
| Researcher | 2 | 9% |
| Other | 1 | 5% |
| Other | 3 | 14% |
| Unknown | 8 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 32% |
| Biochemistry, Genetics and Molecular Biology | 5 | 23% |
| Nursing and Health Professions | 1 | 5% |
| Arts and Humanities | 1 | 5% |
| Unknown | 8 | 36% |